Ednah Ooko | Biochemistry | Innovative Research Award

Innovative Research Award

Ednah Ooko
Affiliation National Institute of Health, National Cancer Institute
Country United States
Scopus ID 57443950800
Documents 9
Citations 13,869
h-index 8
Subject Area Biochemistry
Event International Invention Awards
ORCID 0000-0001-8275-927X

Ednah Ooko

National Institute of Health, National Cancer Institute

Ednah Ooko is a researcher affiliated with the National Institute of Health, National Cancer Institute in the United States. Her scholarly profile reflects contributions within the field of biochemistry, emphasizing investigations that support biomedical discovery and translational cancer research. Through peer-reviewed publications and collaborations, her work contributes to understanding molecular mechanisms relevant to disease progression and therapeutic innovation. The research metrics associated with her academic profile demonstrate measurable scientific visibility, supporting consideration for recognition through the Innovative Research Award presented at the International Invention Awards.[1]

Abstract

Ednah Ooko has established an academic profile focused on biochemistry and cancer-related biomedical research through contributions associated with the National Institute of Health, National Cancer Institute. Her scholarly work demonstrates engagement with molecular investigations supporting improved understanding of disease biology, therapeutic development, and translational medicine. Citation metrics indicate broad recognition of research relevance, while collaborative publications reflect participation in multidisciplinary scientific initiatives. Collectively, these achievements illustrate sustained commitment to advancing biomedical knowledge and enhancing scientific evidence that benefits future clinical investigation, innovation, education, and international collaboration within the global research community through responsible scientific discovery efforts.[1]

Keywords

Biochemistry, Cancer Research, Molecular Biology, Translational Medicine, Biomedical Science, National Cancer Institute, Scientific Innovation, Research Excellence.

Introduction

Modern biomedical science depends upon interdisciplinary investigations capable of translating molecular discoveries into practical healthcare improvements. Researchers working within leading scientific institutions contribute by generating reproducible evidence, advancing laboratory methodologies, and supporting collaborative innovation. Within this environment, Ednah Ooko’s academic activities represent ongoing engagement with biochemical research addressing significant biological questions while contributing to the broader objectives of cancer science and biomedical advancement.[2]

Research Profile

The available scholarly profile identifies Ednah Ooko as a researcher associated with the National Institute of Health, National Cancer Institute, maintaining publication activity within biochemistry. Her indexed research output, citation performance, and international visibility indicate continued participation in scientific collaborations that strengthen biomedical understanding while supporting evidence-based investigation relevant to cancer biology and related molecular disciplines.[1]

Research Contributions

Research contributions attributed to Ednah Ooko demonstrate involvement in studies examining biochemical mechanisms and molecular pathways associated with human disease. Collaborative scientific publications contribute to expanding biomedical knowledge through experimentally supported findings, encouraging future investigations and strengthening the foundation for translational applications that may improve diagnostic approaches, therapeutic strategies, and scientific understanding across multiple biomedical research communities.[3]

Publications

The documented publication record includes peer-reviewed scientific articles indexed within internationally recognized databases. Although the overall publication count remains selective, the accumulated citation performance demonstrates meaningful academic influence. These publications contribute to scientific dialogue by supporting reproducibility, interdisciplinary collaboration, and continued exploration of biochemical processes relevant to cancer research and biomedical innovation.[1]

Research Impact

Research impact extends beyond publication volume through citation influence, collaborative engagement, and scientific relevance. The citation record associated with Ednah Ooko indicates that published findings have informed subsequent investigations, reflecting recognition by the research community. Such influence supports ongoing knowledge development while contributing to biomedical progress through evidence-based scientific communication and responsible dissemination of research outcomes.[4]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating measurable scientific contributions, academic integrity, and influence within their disciplines. Based on available bibliometric indicators, institutional affiliation, scholarly visibility, and contributions to biochemistry and biomedical research, Ednah Ooko presents characteristics consistent with evaluation criteria emphasizing scientific excellence, innovation, collaboration, and continued advancement of internationally relevant research initiatives.[5]

Conclusion

Ednah Ooko’s scholarly profile reflects sustained participation in biomedical and biochemical research supported by recognized institutional affiliation and measurable citation performance. Her research activities contribute to scientific understanding within cancer-related investigations while encouraging collaborative advancement across biomedical disciplines. Collectively, these characteristics provide an appropriate foundation for academic recognition through the Innovative Research Award at the International Invention Awards.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Ednah Ooko, Author ID 57443950800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57443950800
  2. ORCID. (n.d.). Ednah Ooko Research Profile.
    https://orcid.org/0000-0001-8275-927X
  3. Biomolecules.(2025.) Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives.
    https://doi.org/10.3390/biom15070971
  4. Biology (2024.) Identification of Cuproptosis-Associated Prognostic Gene Expression Signatures from 20 Tumor Types.
    https://doi.org/10.3390/biology13100793
  5. International Invention Awards.(2026.) Award Information.
    https://inventionawards.org/

Ivana Vecurkovska | Clinical Biochemistry | Young Scientist Award

Dr. Ivana Vecurkovska | Clinical Biochemistry | Young Scientist Award

Department of Medical and Clinical Biochemistry, Slovakia

Dr. Ivana Vecurkovska is a biomedical researcher specializing in clinical biochemistry, oncology diagnostics, and translational cancer research, currently working as a young talented researcher at Pavol Jozef Safarik University in Kosice and as a researcher at the University of Presov. She earned her PhD in Clinical Biochemistry with a dissertation on the diagnostic potential of the TGF-β/SMAD signaling pathway in colorectal cancer, following RNDr., Master’s, and Bachelor’s degrees in zoology and animal physiology from the same university. Her research expertise includes work with clinical samples, proteomic and genomic techniques (zymography, SDS-PAGE, Western blot, PCR, immunohistochemistry), advanced data analysis, and participation in national and international research projects. Dr. Vecurkovska is actively involved in university teaching across medicine and health care programs, supervising master’s theses, examining students, and contributing to science outreach and popularization initiatives. She has presented her work widely at major international conferences across Europe and completed international mobility programs in Greece and Spain. Her achievements have been recognized with multiple awards, including the Rector’s Award of UPJŠ (2024), best presentation and poster awards in oncology research, and several academic excellence honors.

Citation Metrics (Scopus)

24
20
16
14
12
8
4
0

Citations
24

Documents
11

h-index
3

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Biochemistry | Best Researcher Award

Dr. Saloni Sinha | Weill Cornell Medicine | United States

Dr. Saloni Sinha is a dedicated biomedical researcher currently serving as a Research Associate at a prominent medical college in New York. With a strong foundation shaped by her doctoral studies in biological sciences from a leading Indian research institution, she has progressed through postdoctoral roles in renowned laboratories, contributing to her growing expertise in liver biology and immune regulation. Her work spans from fundamental mechanisms in hematopoietic stem cell biology to in vivo models of viral infection and liver disease. Over the years, her collaborative spirit and scientific rigor have earned her recognition both in the United States and her native country. She combines a deep curiosity with methodological precision, making her a rising figure in translational biomedical research, particularly at the interface of inflammation, aging, and organ function.

Profiles

ORCID

GOOGLE SCHOLAR

Education

Dr. Saloni’s academic journey began with an honours degree in microbiology from a distinguished college in Kolkata, where her interest in cellular biology took root. She then advanced to earn a master’s degree in biological sciences at a leading Indian research centre, where her work under a notable mentor laid the groundwork for her fascination with stem cell regulation and developmental mechanisms. This path naturally progressed into a doctoral program at the same research centre, where she explored the conserved roles of specialized domain proteins in blood cell homeostasis across model systems. The educational environment she experienced was rigorous and research-intensive, honing both her experimental skills and scientific reasoning. These formative years not only forged her technical foundation, but also instilled a passion for uncovering molecular pathways that govern health and disease, setting the stage for her subsequent research career.

Experience

Dr. Saloni embarked on a postdoctoral journey at a prestigious university in the United States, where she refined her expertise in immunology under the guidance of an established professor. She later transitioned to a prominent medical research institution in New York, embarking on a second postdoctoral appointment where she delved deeply into liver biology, inflammation, and aging processes. Her steadfast contributions in that setting led to her current role as a research associate in medicine, where she continues to advance translational studies using both in vitro and in vivo models. Alongside her research responsibilities, she mentors undergraduate interns, contributes as a teaching assistant in graduate courses, and takes part in editorial and peer review activities for a variety of scientific journals, demonstrating a well-rounded engagement with the academic and research community.

Research Interests

Dr. Saloni’s work centers on the interplay between aging, inflammation, and liver health. She investigates how age-related changes in hepatocyte organization and intercellular communication contribute to organ dysfunction, with an eye toward epithelial and fibrotic pathology. Her projects also explore epigenetic strategies to mitigate liver fibrosis and cancer risk, including the potential repurposing of existing therapeutics to alter disease trajectories in aging tissues. Another facet of her research examines innate immune signaling pathways in hematopoiesis as mechanisms of viral defense, notably in the context of lesser-known but emerging pathogens. Together, her interests unify organ-level physiology, molecular signaling, immune modulation, and translational therapeutic avenues. This integrated approach seeks to yield insights into disease prevention and treatment, particularly in age-susceptible populations.

Awards and Recognition

Dr. Saloni’s scientific promise has been acknowledged through several prestigious recognitions. Among these, she received a pilot research award at her current institution in the United States for her exploration of epigenetic regulation of liver inflammation and fibrosis. Her achievements were also recognized nationally in India with a young scientist medal awarded by a leading academy that celebrates emerging promise, creativity, and excellence in early-career investigators. Earlier in her career, she was invited to present her work at an inspiring research symposium at her doctoral institution. During her doctoral years, she also earned accolades for poster presentations at faculty and in-house symposia. These honors reflect both the novelty and impactful nature of her research contributions, as well as her ability to communicate scientific ideas effectively to diverse academic audiences.

Publication Top Notes

Repurposing GLP-1 Receptor Agonists: A Perspective on Epigenetic Strategies to Combat Fibrosis and Hepatocellular Carcinoma in the Aged Liver

Journal: Cancers (2025-08-08)
Authors: Silvia Hanna, Jason Sethiadi, Qazi Ali, Saloni Sinha

Liver-specific Mettl14 deletion induces nuclear heterotypia and dysregulates RNA export machinery

Journal: Preprint (2024-06-17)
Authors: Keith A Berggren, Saloni Sinha, Aaron E Lin, Michael P Schwoerer, Stephanie Maya, Abhishek Biswas, Thomas R Cafiero, Yongzhen Liu, Hans P Gertje, Saori Suzuki et al.

Mesenteric Parametrial Fat Pad Surgery for in vivo Implantation of Hepatocytes in Nude Mice

Journal: BIO-PROTOCOL (2024-01-04)
Authors: Saloni Sinha, Duc-Huy Nguyen, Nora Hassan, Qazi Ali, Jason Sethiadi, Sergey Tsoy, Robert Schwartz

Organelle stress and alterations in interorganelle crosstalk during liver fibrosis

Journal: Hepatology (Baltimore, Md.) (2023-01-03)
Authors: Sinha S, Hassan N, Schwartz RE

Dual-Reporter System for Real-Time Monitoring of SARS-CoV-2 Main Protease Activity in Live Cells Enables Identification of an Allosteric Inhibition Path

Journal: ACS Bio & Med Chem Au (2022-10-17)
Authors: Bram Y, Duan X, Nilsson-Payant BE, Chandar V, Wu H, Shore D, Fajardo A, Sinha S, Hassan N, Weinstein H et al.

Conclusion

Dr. Saloni Sinha is a dynamic researcher whose career trajectory bridges foundational biological inquiry with translational prospects aimed at enhancing liver health and immune resilience. Her academic training and postdoctoral experiences have equipped her with a sophisticated toolkit, while her research output reflects both depth and relevance in contemporary biomedical challenges. Honored by institutions in two countries, she continues to engage with the scientific community through publications, mentorship, editorial service, and presenting her findings. She stands poised to contribute meaningfully to the development of therapeutic strategies that target aging-related diseases, with her work offering valuable insights into organ homeostasis, inflammation, and regenerative potential.